{
    "@graph": [
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A73789959X",
            "@type": "bibo:Thesis",
            "P1053": "Online-Ressource (PDF-Datei: 2,3 MB)",
            "http://purl.org/dc/elements/1.1/contributor": [
                "Mansouri, Ahmed",
                "B\u00e4hr, Mathias",
                "Eichele, Gregor"
            ],
            "creator": "Martinez Hernandez, Ana C.",
            "identifier": [
                "(ppn)73789959X",
                "(firstid)GBV:73789959X"
            ],
            "subject": [
                "(classificationName=ddc-dbn)610",
                "(classificationName=linseach:mapping)meda",
                "(classificationName=ddc-dbn)500"
            ],
            "title": "New genetic mouse models for neurodegenerative diseases: Contribution of noradrenaline to Alzheimer\u02bfs disease pathogenesis and creation of a new genetic model for Parkinson\u02bfs disease.",
            "abstract": [
                "Neurodegenerative Erkrankungen geh\u00f6ren zu den Krankheiten mit den schwerwiegendsten Folgen, f\u00fcr die es bis heute keine Heilung gibt. Mit zunehmendem Alter steigt das Risiko f\u00fcr die Erkrankung. Ein Merkmal, das allen diesen Krankheiten gemeinsam ist, ist die Ablagerung toxischer Proteine. Alzheimer ist gekennzeichnet durch extrazellul\u00e4re Ablagerungen von sogenannten A\u00df-Peptiden, w\u00e4hrend intraneuronale \u03b1-Synuclein Ablagerungen (Lewy-K\u00f6rperchen) symptomatisch f\u00fcr Parkinson sind. Diese Arbeit nutzt genetische Methoden, um offene Fragen \u00fcber diese Krankheiten zu beantworten, die durch bisherige ...",
                "Neurodegenerative diseases are among the most devastating diseases for which there are no cure to date. The greatest risk factor is advancing age. A common feature of these disorders is the toxic aggregation of a peptide particle. In Alzheimer\u02bfs, extracellular A\u03b2 plaques are the pathological hallmark, while in Parkinson\u02bfs (PD), intraneuronal \u03b1 synuclein inclusion bodies (Lewy bodies) mark pathology. This study will focus on the genetic approach to address open questions in these diseases which current genetic models have been unable to do. Although A\u03b2 plaques are the hallmark of AD, the fir..."
            ],
            "contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)GBV-ODiss",
            "issued": "2011",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "relation": "http://creativecommons.org/licenses/by-nc-nd/3.0/"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "license": "http://purl.org/dc/terms/license",
        "relation": "http://purl.org/dc/terms/relation",
        "abstract": "http://purl.org/dc/terms/abstract",
        "contributor": "http://purl.org/dc/terms/contributor",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "title": "http://purl.org/dc/elements/1.1/title",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "creator": "http://purl.org/dc/elements/1.1/creator",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "issued": "http://purl.org/dc/terms/issued",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}